Stockscreener 앱 받기
0.8175
0.36%
0.0029
전일 마감가:
$0.8146
열려 있는:
$0.82
하루 거래량:
378.74K
Relative Volume:
1.05
시가총액:
$34.91M
수익:
$24.38M
순이익/손실:
$-53.95M
주가수익비율:
-0.331
EPS:
-2.47
순현금흐름:
$-23.31M
1주 성능:
+13.07%
1개월 성능:
+50.00%
6개월 성능:
-59.73%
1년 성능:
-74.53%
1일 변동 폭
$0.74
$0.8499
1주일 범위
$0.68
$0.9112
52주 변동 폭
$0.50
$3.46
Elutia Inc Stock (ELUT) Company Profile
명칭
Elutia Inc
전화
240-247-1143
주소
12510 PROSPERITY DRIVE, SILVER SPRING
ELUT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.8175 | 34.78M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 개시 | Cowen | Outperform |
| 2020-11-02 | 개시 | Piper Sandler | Overweight |
| 2020-11-02 | 개시 | Truist | Buy |
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia sees Q4 net sales of $3.3M - MSN
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Elutia reports 16% revenue growth, advances breast reconstruction product By Investing.com - Investing.com Nigeria
Elutia reports 16% revenue growth, advances breast reconstruction product - Investing.com
Elutia (ELUT) Strengthens Position with Drug-Eluting Platform - GuruFocus
Elutia reports preliminary fourth quarter 2025 results, strengthened financial position, and upcoming Nxt-41X milestones - marketscreener.com
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, And Upcoming Nxt-41X Milestones - TradingView — Track All Markets
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - The Manila Times
Elutia, Inc.Class A Common Stock (NQ: ELUT - FinancialContent
Elutia (NASDAQ:ELUT) Shares Up 4.7% – Should You Buy? - Defense World
Elutia Inc. to Highlight NXT-41x Program at Inaugural Global BioInnovation Forum during JP Morgan Healthcare Conference - Quiver Quantitative
Breast reconstruction infections hit 25% of patients. A new approach emerges - Stock Titan
Why Elutia Inc. stock attracts high net worth investorsWeekly Profit Recap & Safe Entry Zone Tips - ulpravda.ru
Why Elutia Inc. stock could rally in 2025Weekly Volume Report & Weekly Momentum Stock Picks - Улправда
How Elutia Inc. stock reacts to job market dataMarket Volume Summary & Daily Risk Controlled Trade Plans - Улправда
Will Elutia Inc. stock gain from strong economy2025 Price Momentum & Daily Chart Pattern Signal Reports - ulpravda.ru
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc (ELUT) upgraded to buy: Here's what you should know - MSN
Gaithersburg biotech Elutia battles to keep Nasdaq listing after asset sale - The Business Journals
Where Analysts See Viviana Power Tech Limited Stock by YearEndTechnical Analysis Insights & Small Investment Growth Plans - earlytimes.in
Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing - The Globe and Mail
Earnings Risk: Why Elutia Inc stock attracts high net worth investorsBond Market & Breakout Confirmation Alerts - moha.gov.vn
Elutia receives Nasdaq notice for non-compliance with market value and bid price rules - Investing.com India
Elutia Received Notice of Noncompliance - TradingView — Track All Markets
Elutia faces Nasdaq noncompliance, considers options to regain listing - MSN
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Is Elutia Stock Built to Withstand More Downside? - Trefis
Aug Volume: What insider trading reveals about Elutia Inc. stockQuarterly Earnings Report & Long-Term Safe Return Strategies - moha.gov.vn
Why Elutia Inc. stock remains a top recommendationWeekly Profit Recap & Consistent Return Strategy Ideas - Улправда
Is Elutia Inc. stock gaining market shareEarnings Risk Report & Expert Verified Stock Movement Alerts - Улправда
Published on: 2025-12-20 12:45:53 - Улправда
What insider trading reveals about Elutia Inc. stockBreakout Watch & Fast Gain Swing Alerts - Улправда
ELUT FinancialsIncome Statement - Quiver Quantitative
Is Elutia Inc. stock near bottom after decline2025 Performance Recap & High Return Trade Opportunity Guides - Улправда
Will Elutia Inc. stock deliver consistent dividendsM&A Rumor & Risk Controlled Daily Plans - ulpravda.ru
How risky is Elutia Inc. stock nowWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда
[Form 4/A] ELUTIA INC. Amended Insider Trading Activity - Stock Titan
Insiders Make Bold Move on Elutia Stock With Fresh Buying Spree - TipRanks
[Form 4] ELUTIA INC. Insider Trading Activity - Stock Titan
Elutia (NASDAQ: ELUT) director reports purchase of 12,500 Class A shares - Stock Titan
Published on: 2025-12-19 04:35:35 - Улправда
ELUTIA Executives Increase Their Holdings - TradingView — Track All Markets
CFO Ferguson Buys 60,000 ($31.8K) Of Elutia Inc [ELUT] - TradingView — Track All Markets
Published on: 2025-12-18 16:42:06 - ulpravda.ru
Elutia Earnings Notes - Trefis
Buyout Rumor: How strong is Elutia Inc stock balance sheet2025 Fundamental Recap & Target Return Focused Picks - moha.gov.vn
Elutia Inc (ELUT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Elutia Inc 주식 (ELUT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RAKIN KEVIN | Director |
Dec 17 '25 |
Buy |
0.52 |
50,000 |
25,995 |
322,419 |
| Colpman David | Director |
Dec 17 '25 |
Buy |
0.51 |
12,500 |
6,375 |
31,098 |
| Makes Brigid | Director |
Dec 17 '25 |
Buy |
0.52 |
25,000 |
13,000 |
27,000 |
| Mills C Randal | PRESIDENT AND CEO |
Dec 17 '25 |
Buy |
0.51 |
3,000 |
1,530 |
379,204 |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER |
Dec 17 '25 |
Buy |
0.53 |
60,000 |
31,800 |
447,110 |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER |
Dec 02 '25 |
Buy |
0.67 |
5,500 |
3,685 |
379,071 |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER |
Dec 01 '25 |
Buy |
0.65 |
4,500 |
2,925 |
373,571 |
| Mills C Randal | PRESIDENT AND CEO |
Nov 24 '25 |
Buy |
0.60 |
5,000 |
3,000 |
358,785 |
| Colpman David | Director |
Nov 17 '25 |
Buy |
0.74 |
15,500 |
11,470 |
18,598 |
| Mills C Randal | PRESIDENT AND CEO |
Nov 13 '25 |
Buy |
0.75 |
13,500 |
10,110 |
353,785 |
0.42%
1.96%
자본화:
|
볼륨(24시간):